PI(20:3(8Z,11Z,14Z)/18:1(11Z))

Term ID

CHEBI:89142

Synonyms

1-(8Z,11Z,14Z-Eicosatrienoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
1-Homo-g-linolenoyl-2-vaccenoyl-sn-glycero-3-phosphoinositol
1-Homo-gamma-linolenoyl-2-vaccenoyl-sn-glycero-3-phosphoinositol
[(2R)-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]-2-[(11Z)-octadec-11-enoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Phosphatidylinositol(20:3/18:1)
Phosphatidylinositol(20:3n6/18:1n7)
Phosphatidylinositol(20:3w6/18:1w7)
Phosphatidylinositol(38:4)
PI(20:3/18:1)
PI(20:3n6/18:1n7)
PI(20:3w6/18:1w7)
PI(38:4)
PIno(20:3/18:1)
PIno(20:3n6/18:1n7)
PIno(20:3w6/18:1w7)
PIno(38:4)

(all 16)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PI(20:3(8Z,11Z,14Z)/18:1(11Z))

No data available

Phenotype where environments contain PI(20:3(8Z,11Z,14Z)/18:1(11Z))

No data available

Phenotype modified by environments containing PI(20:3(8Z,11Z,14Z)/18:1(11Z))

No data available

Phenotype affecting PI(20:3(8Z,11Z,14Z)/18:1(11Z))

No data available

Human Disease Model

No data available